First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - MAXCARE PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: MAXCARE PHARMACEUTICALS LIMITED, FLAT 29 BATEMAN HOUSE, OTTO STREET, LONDON, SE17 3PF. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 31 December 2021. The company was incorporated on 17 December 2020.

The accounts next due date is 30 September 2023. There are no mortgages.

The above was based on public record information as at 23 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13088092
Date Incorporated: 17 December 2020
Date Latest Accounts: 31 December 2021
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 13088092
Annual Return: Unknown
Registered Office: FLAT 29 BATEMAN HOUSE, OTTO STREET, LONDON, SE17 3PF
SIC Code and Operations: 46460
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

MAXCARE PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 2 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
10738913 MAXCARS LTD Active - Proposal to Strike off
11507251 MAXCART LIMITED Active - Proposal to Strike off
15500818 MAXCART LTD Active
08377907 MAXCARTER LIMITED Active - Proposal to Strike off
12808929 MAXCAST ACCOUNTANCY LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd